Related Experiment Video
Updated: Sep 23, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Involvement of p38MAP kinase in bone morphogenetic protein-4-induced osteoprotegerin in mouse bone-marrow-derived
Michiko Tazoe1, Makio Mogi, Shigemi Goto
1Department of Pharmacology, School of Dentistry, Aichi-Gakuin University, Nagoya 464-8650, Japan.
Abstract:
Osteoprotegerin (OPG)/osteoclastogenesis inhibitory factor is a recently identified cytokine that belongs to the tumour necrosis factor receptor superfamily and regulates bone mass by inhibiting osteoclastic bone resorption. This study found that bone morphogenetic protein (BMP)-4 markedly increased the level of soluble OPG in the mouse bone-marrow-derived stromal cell line, ST2. In contrast, BMP-4 showed no effect on OPG ligand production in ST2 cells under similar conditions. Using an in vitro immunocomplex kinase assay, BMP-4 was found to activate p38 mitogen-activated protein (MAP) kinase. Pre-treatment of ST2 cells with SB203580 (a specific inhibitor of p38MAP kinase) inhibited BMP-4-induced increase in OPG, although PD98059 (a specific inhibitor of classic MAP kinase cascade) showed no effect on OPG production. These results clearly suggest that activation of the p38MAP kinase pathway is necessary for BMP-4-induced OPG induction in ST2 cells.
Insights
Bone morphogenetic protein (BMP)-4 increases soluble osteoprotegerin (OPG) levels in ST2 cells by activating p38 MAP kinase. This pathway is crucial for BMP-4-induced OPG production, regulating bone resorption.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Osteoprotegerin (OPG) is a cytokine regulating bone mass by inhibiting osteoclastic bone resorption.
- OPG belongs to the tumor necrosis factor receptor superfamily.
Purpose of the Study:
- To investigate the effect of bone morphogenetic protein (BMP)-4 on OPG production in ST2 cells.
- To elucidate the signaling pathway involved in BMP-4-induced OPG production.
Main Methods:
- Mouse bone-marrow-derived stromal cell line (ST2) treated with BMP-4.
- Measurement of soluble OPG levels.
- In vitro immunocomplex kinase assay to assess MAP kinase activation.
- Inhibition studies using SB203580 (p38 MAP kinase inhibitor) and PD98059 (classic MAP kinase inhibitor).
Main Results:
- BMP-4 significantly increased soluble OPG levels in ST2 cells.
- BMP-4 did not affect OPG ligand production.
- BMP-4 activated p38 MAP kinase.
- SB203580, but not PD98059, inhibited BMP-4-induced OPG increase.
Conclusions:
- BMP-4 induces OPG production in ST2 cells.
- Activation of the p38 MAP kinase pathway is essential for BMP-4-induced OPG induction.
- This finding provides insight into the molecular mechanisms regulating bone resorption.
More Related Videos
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
10:32Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
Published on: May 19, 2023
Related Concept Videos
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway